Wave Life Sciences
WVE
115 hedge funds and large institutions have $468M invested in Wave Life Sciences in 2023 Q4 according to their latest regulatory filings, with 40 funds opening new positions, 48 increasing their positions, 11 reducing their positions, and 10 closing their positions.
826% more call options, than puts
Call options by funds: $1.52M | Put options by funds: $164K
336% more repeat investments, than reductions
Existing positions increased: 48 | Existing positions reduced: 11
300% more first-time investments, than exits
New positions opened: 40 | Existing positions closed: 10
35% more funds holding
Funds holding: 85 → 115 (+30)
12% more capital invested
Capital invested by funds: $417M → $468M (+$50.6M)
4.4% more ownership
Funds ownership: 73.35% → 77.75% (+4.4%)
0% more funds holding in top 10
Funds holding in top 10: 3 → 3 (0)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Point72 Asset Management
Stamford,
Connecticut
|
+$17.2M |
| 2 |
Adage Capital Partners
Boston,
Massachusetts
|
+$11.8M |
| 3 |
Citadel Advisors
Miami,
Florida
|
+$10.6M |
| 4 |
MC
Maverick Capital
Dallas,
Texas
|
+$9.91M |
| 5 |
MS
Maven Securities
St Helier,
Jersey
|
+$7.76M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
6CM
683 Capital Management
New York
|
-$1.34M |
| 2 |
Mirae Asset Global Investments
Seoul,
South Korea
|
-$273K |
| 3 |
XT
XTX Topco
George Town,
Cayman Islands
|
-$186K |
| 4 |
JF
Jump Financial
Chicago,
Illinois
|
-$135K |
| 5 |
Verition Fund Management
Greenwich,
Connecticut
|
-$113K |
WVE Hedge Fund Activity: Q4 2023 in Review
115 of the 6,869 institutional investors tracked by Wall St. Rank reported a position in Wave Life Sciences (WVE) for Q4 2023, worth a combined $468M — up 12% from $417M a quarter earlier.
Buyers outnumbered sellers: 40 funds opened new WVE positions and 10 closed out — a net gain of 30 holders — while 48 added to existing stakes and 11 trimmed.
The largest buyer was Point72 Asset Management, opening a new position worth an estimated $17.2M. The largest seller was 683 Capital Management, cutting an estimated $1.34M.
- 115 institutional investors held Wave Life Sciences (WVE) as of Q4 2023, up from 85 in Q3 2023.
- Funds reported $468M of Wave Life Sciences stock for Q4 2023, up 12% quarter-over-quarter.
- 40 funds opened new Wave Life Sciences positions in Q4 2023 and 10 closed out, a net change of +30 holders.
- The largest Wave Life Sciences buyer in Q4 2023 was Point72 Asset Management, an estimated $17.2M added.
- The largest Wave Life Sciences seller in Q4 2023 was 683 Capital Management, an estimated $1.34M sold.
Based on aggregated 13F filings for Q4 2023.